Gautam Buddh Nagar Stamp Revenue Surges by Rs 5 Bn due to Registries

Apollo Green Energy targets Rs 100 billion in renewables

Apollo Green Energy Limited (AGEL), a subsidiary of Apollo International Group, is set to grow its renewable energy portfolio to Rs 100 billion by 2025, with plans for an initial public offering (IPO) to fuel this expansion. AGEL currently holds an order book of Rs 35 billion and manages Rs 25 billion in solar projects across several states. Operating in eight states, AGEL’s portfolio includes 400 MW of solar power installations and a Rs 7 billion Flue Gas Desulfurization (FGD) project aimed at reducing emissions in power generation. These projects support India’s ambitious target of reac..

Kolkata Metro’s Orange Line Phase II deadline moved to March 2025

The completion date for the Orange Line's Phase II extension, stretching from Ruby to Sector V, has been shifted to March 2025. Rail Vikas Nigam Ltd. (RVNL), the agency overseeing the project, initially aimed for a December 2024 deadline but cited a delay in bridging an 800-meter viaduct gap at Chingrighata as the reason for the revised schedule. Work to bridge an additional 125-meter gap at Metropolitan is ongoing. Despite land challenges at locations such as Tagore Park, Chingrighata, and Nicco Park, the corridor received safety approval from the Commission of Railway Safety (CRS) for opera..

Solar efficiency, cost cuts vital for energy transition: Pralhad Joshi

Union Minister for New and Renewable Energy, Pralhad Joshi, emphasised the global focus on advancing solar technology to achieve significant cost reductions and efficiency gains during a conference on clean energy transition. As President of the International Solar Alliance (ISA), he remarked, “The world is united in the energy transition, harnessing global efforts.” Joshi highlighted the need for more efficient solar technology, stating, “Traditional solar panels typically convert only 15-20% of sunlight to electricity, but innovations like bifacial panels and solar paint are increasin..